Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
3
75%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
unknown250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Updated Diagnostic Cortisol Values for Adrenal Insufficiency

NCT05149638
recruitingearly_phase_1

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

NCT06190158
unknownnot_applicable

Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease

NCT03793114
unknownnot_applicable

Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients

NCT03083834

Clinical Trials (4)

Showing 4 of 4 trials
NCT05149638Not Applicable

Updated Diagnostic Cortisol Values for Adrenal Insufficiency

Recruiting
NCT06190158Early Phase 1

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Recruiting
NCT03793114Not Applicable

Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease

Unknown
NCT03083834Not Applicable

Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4